BIO-RAD LABORATORIES -CL B (BIO.B) Stock Price & Overview
NYSE:BIO.B • US0905721082
The current stock price of BIO.B is 268.495 USD. Today BIO.B is down by -4.77%. In the past month the price increased by 1.01%. In the past year, price decreased by -64.8%.
BIO.B Key Statistics
- Market Cap
- 7.247B
- P/E
- 27.07
- Fwd P/E
- 25.88
- EPS (TTM)
- 9.92
- Dividend Yield
- N/A
BIO.B Stock Performance
BIO.B Stock Chart
BIO.B Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to BIO.B. When comparing the yearly performance of all stocks, BIO.B is a bad performer in the overall market: 93.19% of all stocks are doing better.
BIO.B Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to BIO.B. BIO.B has an excellent financial health rating, but there are some minor concerns on its profitability.
BIO.B Earnings
On February 12, 2026 BIO.B reported an EPS of 2.51 and a revenue of 693.20M. The company missed EPS expectations (-7.97% surprise) and missed revenue expectations (-0.35% surprise).
BIO.B Forecast & Estimates
10 analysts have analysed BIO.B and the average price target is 342.51 USD. This implies a price increase of 27.57% is expected in the next year compared to the current price of 268.495.
For the next year, analysts expect an EPS growth of 4.57% and a revenue growth 1.81% for BIO.B
BIO.B Groups
Sector & Classification
BIO.B Financial Highlights
Over the last trailing twelve months BIO.B reported a non-GAAP Earnings per Share(EPS) of 9.92. The EPS decreased by -3.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 29.42% | ||
| ROA | 7.18% | ||
| ROE | 10.2% | ||
| Debt/Equity | 0.16 |
BIO.B Ownership
BIO.B Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.99 | 185.77B | ||
| DHR | DANAHER CORP | 23.09 | 138.048B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 134.98 | 44.453B | ||
| A | AGILENT TECHNOLOGIES INC | 17.26 | 32.632B | ||
| WAT | WATERS CORP | 20.46 | 29.394B | ||
| IQV | IQVIA HOLDINGS INC | 13.43 | 28.694B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.33 | 25.041B | ||
| ILMN | ILLUMINA INC | 23.38 | 18.707B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 29.15 | 16.84B | ||
| MEDP | MEDPACE HOLDINGS INC | 27.3 | 13.248B | ||
| RVTY | REVVITY INC | 16.35 | 10.096B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 9.099B | ||
| TECH | BIO-TECHNE CORP | 23.9 | 8.264B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BIO.B
Company Profile
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. The company is headquartered in Hercules, California and currently employs 7,450 full-time employees. The firm offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Company Info
IPO: 1980-03-17
BIO-RAD LABORATORIES -CL B
1000 Alfred Nobel Dr
Hercules CALIFORNIA US
CEO: Norman Schwartz
Employees: 7450
Phone: 15107247000
BIO-RAD LABORATORIES -CL B / BIO.B FAQ
What does BIO-RAD LABORATORIES -CL B do?
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. The company is headquartered in Hercules, California and currently employs 7,450 full-time employees. The firm offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Can you provide the latest stock price for BIO-RAD LABORATORIES -CL B?
The current stock price of BIO.B is 268.495 USD. The price decreased by -4.77% in the last trading session.
Does BIO-RAD LABORATORIES -CL B pay dividends?
BIO.B does not pay a dividend.
How is the ChartMill rating for BIO-RAD LABORATORIES -CL B?
BIO.B has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Should I buy BIO.B stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BIO.B.
What is the market capitalization of BIO.B stock?
BIO-RAD LABORATORIES -CL B (BIO.B) has a market capitalization of 7.25B USD. This makes BIO.B a Mid Cap stock.
Can you provide the ownership details for BIO.B stock?
You can find the ownership structure of BIO-RAD LABORATORIES -CL B (BIO.B) on the Ownership tab.